JUNSHI BIO Revamps Board Committee to Include ESG Oversight

Stock News
03/13

JUNSHI BIO (01877) has announced that its board of directors has passed a resolution to reconfigure the existing Strategy Committee into a Strategy and ESG Committee, effective March 13, 2026. This adjustment is intended to enhance the company's management of environmental, social, and governance (ESG) standards and bolster its sustainable development capabilities. The change is made in accordance with relevant legal provisions and the company's articles of association, taking into account its current operational context. The corresponding internal guidelines have also been updated from the "Strategy Committee Working Rules" to the "Strategy and ESG Committee Working Rules," expanding the committee's responsibilities to include ESG management alongside its existing functions. The Strategy and ESG Committee will primarily focus on studying the company's long-term development strategy, major investment decisions, sustainability, and ESG matters, providing recommendations to the board. This update only affects the committee's name and duties; its membership composition and term regulations remain unchanged.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10